Antigeno polisacarido meningococo grupo a, Antigeno polisacarido meningococo grupo c, Antigeno polisacarido meningococo gr w-135, Antigeno polisacarido meningococo gr y, Toxóide tetânico

Menquadfi Solución Inyectable

10 µg + 10 µg + 10 µg + 10 µg + 55 µg solución inyectableSpainMarketedAuthorised 17 Jul 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

MenQuadfiEuropean UnionAuthorised

Packs

Pack	Code	Status
MENQUADFI SOLUCIÓN INYECTABLE, 10 viales de 0,5 ml	763017

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Antigeno polisacarido meningococo grupo a, Antigeno polisacarido meningococo grupo c, Antigeno polisacarido meningococo gr w-135, Antigeno polisacarido meningococo gr y, Toxóide tetânico

Menquadfi Solución Inyectable

10 µg + 10 µg + 10 µg + 10 µg + 55 µg solución inyectableSpainMarketedAuthorised 17 Jul 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

MenQuadfiEuropean UnionAuthorised

Packs

Pack	Code	Status
MENQUADFI SOLUCIÓN INYECTABLE, 10 viales de 0,5 ml	763017

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Antigeno polisacarido meningococo grupo a, Antigeno polisacarido meningococo grupo c, Antigeno polisacarido meningococo gr w-135, Antigeno polisacarido meningococo gr y, Toxóide tetânico
Strength: 10 µg + 10 µg + 10 µg + 10 µg + 55 µg
Dosage form: solución inyectable
Route: vía intramuscular
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 17 Jul 2023
Registration: 1201483004
Marketing authorisation holder: Sanofi Winthrop Industrie
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica
EU number: EU/1/20/1483

Antigeno polisacarido meningococo grupo a + Antigeno polisacarido meningococo grupo c + Antigeno polisacarido meningococo gr w-135 + Antigeno polisacarido meningococo gr y + Toxóide tetânico · 20 microgramos/ml + 20 microgramos/ml + 20 microgramos/ml + 20 microgramos/ml + 110 microgramos/ml · solución inyectable

Spain